BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 15683501)

  • 1. Carvedilol versus metoprolol in the acute phase of myocardial infarction:
    Bonnemeier H; Ortak J; Tölg R; Witt M; Schmidt J; Wiegand UK; Bode F; Schunkert H; Richardt G
    Pacing Clin Electrophysiol; 2005 Jan; 28 Suppl 1():S222-6. PubMed ID: 15683501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carvedilol versus metoprolol in patients undergoing direct percutaneous coronary interventions for myocardial infarction: effects on QT dynamicity.
    Bonnemeier H; Ortak J; Tölg R; Witt M; Schmidt J; Wiegand UK; Bode F; Schunkert H; Richardt G
    Pacing Clin Electrophysiol; 2005 Jan; 28 Suppl 1():S217-21. PubMed ID: 15683500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized active-controlled study comparing effects of treatment with carvedilol versus metoprolol in patients with left ventricular dysfunction after acute myocardial infarction.
    Mrdovic IB; Savic LZ; Perunicic JP; Asanin MR; Lasica RM; Jelena MM; Matic MD; Vasiljevic ZM; Ostojic MC
    Am Heart J; 2007 Jul; 154(1):116-22. PubMed ID: 17584563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective versus nonselective beta-adrenergic receptor blockade in chronic heart failure: differential effects on myocardial energy substrate utilization.
    Al-Hesayen A; Azevedo ER; Floras JS; Hollingshead S; Lopaschuk GD; Parker JD
    Eur J Heart Fail; 2005 Jun; 7(4):618-23. PubMed ID: 15921803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of carvedilol and metoprolol in patients with acute myocardial infarction undergoing primary coronary intervention--the PASSAT Study.
    Tölg R; Witt M; Schwarz B; Kurz T; Kurowski V; Hartmann F; Geist V; Richardt G
    Clin Res Cardiol; 2006 Jan; 95(1):31-41. PubMed ID: 16598443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effects of carvedilol and metoprolol on left ventricular ejection fraction in heart failure: results of a meta-analysis.
    Packer M; Antonopoulos GV; Berlin JA; Chittams J; Konstam MA; Udelson JE
    Am Heart J; 2001 Jun; 141(6):899-907. PubMed ID: 11376302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exchange of beta-blockers in heart failure patients. Experiences from the poststudy phase of COMET (the Carvedilol or Metoprolol European Trial).
    Di Lenarda A; Remme WJ; Charlesworth A; Cleland JG; Lutiger B; Metra M; Komajda M; Torp-Pedersen C; Scherhag A; Swedberg K; Poole-Wilson PA;
    Eur J Heart Fail; 2005 Jun; 7(4):640-9. PubMed ID: 15921806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carvedilol administration in acute myocardial infarction results in stronger inhibition of early markers of left ventricular remodeling than metoprolol.
    Cimmino G; Ibanez B; Giannarelli C; Prat-González S; Hutter R; Garcia M; Sanz J; Fuster V; Badimon JJ
    Int J Cardiol; 2011 Dec; 153(3):256-61. PubMed ID: 20864196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of carvedilol in comparison with metoprolol on myocardial collagen postinfarction.
    Wei S; Chow LT; Sanderson JE
    J Am Coll Cardiol; 2000 Jul; 36(1):276-81. PubMed ID: 10898446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-receptor selectivity of carvedilol and metoprolol succinate in patients with heart failure (SELECT trial): a randomized dose-ranging trial.
    Zebrack JS; Munger M; Macgregor J; Lombardi WL; Stoddard GP; Gilbert EM
    Pharmacotherapy; 2009 Aug; 29(8):883-90. PubMed ID: 19637941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative hemodynamic, left ventricular functional, and antiadrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart.
    Gilbert EM; Abraham WT; Olsen S; Hattler B; White M; Mealy P; Larrabee P; Bristow MR
    Circulation; 1996 Dec; 94(11):2817-25. PubMed ID: 8941107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative effects of carvedilol and metoprolol in preventing from left ventricular remodeling after acute myocardial infarction in rats].
    Tang YD; Yang YJ; Zhang P; Ruan YM; Lu SQ; Sun RC; Wang PH; Gao RL; Chen JL; Chen ZJ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Oct; 23(5):476-80. PubMed ID: 12905866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-blockade in heart failure: a comparison of carvedilol with metoprolol.
    Sanderson JE; Chan SK; Yip G; Yeung LY; Chan KW; Raymond K; Woo KS
    J Am Coll Cardiol; 1999 Nov; 34(5):1522-8. PubMed ID: 10551702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of metoprolol and carvedilol on cause-specific mortality and morbidity in patients with chronic heart failure--COMET.
    Torp-Pedersen C; Poole-Wilson PA; Swedberg K; Cleland JG; Di Lenarda A; Hanrath P; Komajda M; Lutiger B; Metra M; Remme WJ; Scherhag A; Skene A;
    Am Heart J; 2005 Feb; 149(2):370-6. PubMed ID: 15846279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carvedilol exerts more potent antiadrenergic effect than metoprolol in heart failure.
    Kohno T; Yoshikawa T; Yoshizawa A; Nakamura I; Anzai T; Satoh T; Ogawa S
    Cardiovasc Drugs Ther; 2005 Oct; 19(5):347-55. PubMed ID: 16382297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative effects of cilazapril, carvedilol and their combination in preventing from left ventricular remodelling after acute myocardial infarction in rats.
    Yang Y; Tang Y; Ruan Y; Li Y; Zhou Y; Gao R; Chen J; Chen Z
    J Renin Angiotensin Aldosterone Syst; 2002 Mar; 3(1):31-5. PubMed ID: 11984745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the two beta-blockers carvedilol and atenolol on left ventricular ejection fraction and clinical endpoints after myocardial infarction. a single-centre, randomized study of 232 patients.
    Jonsson G; Abdelnoor M; Müller C; Kjeldsen SE; Os I; Westheim A
    Cardiology; 2005; 103(3):148-55. PubMed ID: 15785019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of combined versus selective adrenergic blockade on left ventricular and systemic hemodynamics, myocardial substrate preference, and regional perfusion in conscious dogs with dilated cardiomyopathy.
    Nikolaidis LA; Poornima I; Parikh P; Magovern M; Shen YT; Shannon RP
    J Am Coll Cardiol; 2006 May; 47(9):1871-81. PubMed ID: 16682315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carvedilol: use in chronic heart failure.
    Doughty RN; White HD
    Expert Rev Cardiovasc Ther; 2007 Jan; 5(1):21-31. PubMed ID: 17187454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of beta-blocker use on cyclosporine level in cardiac transplant recipients.
    Bader FM; Hagan ME; Crompton JA; Gilbert EM
    J Heart Lung Transplant; 2005 Dec; 24(12):2144-7. PubMed ID: 16364863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.